Senate Labor Cmte.'s comprehensive FDA reform bill could be focus of mid-July hearing.
This article was originally published in The Gray Sheet
Executive Summary
SENATE LABOR COMMITTEE'S COMPREHENSIVE FDA REFORM BILL could be the focus of a committee hearing on the agency tentatively scheduled for mid-July, according to staffers. While a specific date or agenda for the proposed hearing has not been set, staffers indicate that FDA reform legislation currently being drafted by the committee could be discussed. The hearing also could address specific FDA programs.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.